Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.

about

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.

Item

http://www.wikidata.org/entity/Q48098961

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Risk scoring tool to predict r ...... lisation in premature infants.

@en

Risk scoring tool to predict r ...... lisation in premature infants.

@nl

type

Item

label

Risk scoring tool to predict r ...... lisation in premature infants.

@en

Risk scoring tool to predict r ...... lisation in premature infants.

@nl

prefLabel

Risk scoring tool to predict r ...... lisation in premature infants.

@en

Risk scoring tool to predict r ...... lisation in premature infants.

@nl

P1476

Risk scoring tool to predict r ...... lisation in premature infants.

@en

P2093

Barry S Rodgers-Gray

http://www.w3.org/2001/XMLSchema#string

Bosco Paes

http://www.w3.org/2001/XMLSchema#string

ElizaBeth Grubb

http://www.w3.org/2001/XMLSchema#string

Evan J Anderson

http://www.w3.org/2001/XMLSchema#string

Gerard Notario

http://www.w3.org/2001/XMLSchema#string

John R Fullarton

http://www.w3.org/2001/XMLSchema#string

Marcello Lanari

http://www.w3.org/2001/XMLSchema#string

Margaret Sheridan-Pereira

http://www.w3.org/2001/XMLSchema#string

Scot Buchan

http://www.w3.org/2001/XMLSchema#string

Xavier Carbonell-Estrany

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

Challenges and opportunities in developing respiratory syncytial virus therapeutics

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.

Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.

Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study

Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort.

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).

P31

scholarly article

P356

10.1002/PPUL.23960

http://www.w3.org/2001/XMLSchema#string

P50

Maarten O Blanken

P577

2018-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29405612

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

6099524

http://www.w3.org/2001/XMLSchema#string